logo

For the Inventor, By the Inventor

Seoul, South Korea

Hyun-Su Bae

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Twinpigbiolab Inc.. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hyun-Su Bae. Retrieved from https://idiyas.com/inventor/hyun-su-bae-7jhb53io

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:

goldMedal1 out of 1 
 
Twinpigbiolab Inc.
 patent

Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents
1. 11484601 - Targeting M2-like tumor-associated macrophages by using melittin-based proapoptotic peptide (2022-11-01),

Title: Innovations of Hyun-Su Bae in Cancer Treatment

Introduction

Hyun-Su Bae is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of cancer treatment through his innovative research and development of targeted therapies. His work focuses on utilizing unique compounds to enhance the effectiveness of anticancer drugs.

Latest Patents

Hyun-Su Bae holds a patent for a groundbreaking invention titled "Targeting M2-like tumor-associated macrophages by using melittin-based proapoptotic peptide." This invention relates to a melittin-anticancer drug conjugate, where melittin is combined with an anticancer drug. The conjugate is designed to target M2-type tumor-associated macrophages (TAM), demonstrating an excellent ability to selectively identify and affect these cells. This innovative approach may significantly improve drug delivery systems aimed at M2-type TAMs.

Career Highlights

Hyun-Su Bae is currently associated with Twinpigbiolab Inc., where he continues to advance his research in cancer therapies. His work has garnered attention for its potential to revolutionize treatment options for patients suffering from cancer. With a focus on targeted therapies, he aims to enhance the efficacy of existing treatments.

Collaborations

Hyun-Su Bae collaborates with talented individuals in his field, including Do-Ha Lee and Jin-Hyun Jeong. These partnerships foster a creative environment that encourages innovation and the development of new therapeutic strategies.

Conclusion

Hyun-Su Bae's contributions to cancer treatment through his innovative patent highlight the importance of targeted therapies in modern medicine. His work exemplifies the potential of combining unique compounds to improve drug delivery and treatment outcomes for cancer patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…